Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
NRC Health (National Research Corporation, NASDAQ: NRC) generates a steady stream of news focused on healthcare experience management, financial performance, and partnerships with health systems. This news page aggregates updates from company press releases, third-party announcements, and regulatory disclosures so readers can follow how NRC Health is working with healthcare organizations and how its business is evolving over time.
Many NRC Health news items highlight new and expanded partnerships with hospitals and health systems. Recent examples include collaborations with Mosaic Life Care, BJC Health System, North Mississippi Health Services, and South Shore Health. These announcements describe how NRC Health’s patient experience, employee experience, and market insight capabilities are being used to support human-centered care, unify feedback, and guide improvement across hospitals, clinics, and other care settings.
Investors and industry observers will also find coverage of NRC Health’s quarterly results, including revenue trends, Total Recurring Contract Value (TRCV), cash flow from operations, and non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income. These earnings releases often include commentary from company leadership about sales activity, customer retention, and capital allocation through dividends and share repurchases.
Additional news includes leadership appointments, such as executive roles in finance and strategic insights, and recognition related to healthcare experience management, including references to the Best in KLAS Award for Healthcare Experience Management and Excellence in Patient Experience awards given by NRC Health to client organizations. Readers who want to monitor NRC Health’s role in healthcare experience improvement, its relationships with health systems, and its public company disclosures can use this page as a centralized source of updates.
NRC Health, a leader in personalized healthcare solutions, has announced its sponsorship of the Creative Learning Event Series organized by the Society for Participatory Medicine (SPM). This year-long initiative aims to enhance patient-provider relationships and promote equity in healthcare. The first event will be held on October 20, 2022, in Boston, focusing on access to care in underserved communities. NRC Health's support aligns with its mission of achieving Human Understanding, emphasizing collaboration among patients and healthcare professionals.
NRC Health announced a quarterly cash dividend of $0.24 per share, payable on October 14, 2022, to shareholders on record by September 30, 2022. This decision reflects NRC Health's ongoing commitment to returning value to its investors. With over 40 years of experience, NRC Health focuses on enhancing healthcare experiences and building trust within organizations through innovative methods and skilled associates.
NRC Health announced the winners of its 2022 Consumer Loyalty Awards and Excellence in Patient Experience Awards. This year, top hospitals were acknowledged for exceptional patient experiences amidst ongoing healthcare challenges post-pandemic. The Consumer Loyalty Awards spotlighted the top 100 healthcare facilities focusing on cultivating long-lasting loyalty, with ten facilities designated as Best-In-Class. The Excellence in Patient Experience Awards recognized hospitals for their commitment to improving patient care, based on Net Promoter Scores from patient surveys.
NRC Health announced its new role as a Diamond Supporting Partner with The Beryl Institute, emphasizing a commitment to enhancing patient experience through collaboration. This partnership aims to provide resources and opportunities for healthcare organizations to better serve patients. Helen Hrdy, Chief Growth Officer, underscored the critical need for patient-centered care. NRC Health has actively supported The Beryl Institute through past events and will now contribute to expanding the community's content and access to resources for members globally.
On August 2, 2022, National Research Corporation (NASDAQ:NRC) reported a 2% increase in Q2 2022 revenue, totaling $37.3 million, compared to $36.4 million in Q2 2021. However, operating income fell by 6% to $11.5 million, with net income decreasing to $8.3 million from $8.9 million. Diluted earnings per share also declined to $0.33. The company secured its first contract for the Human Understanding Program with Novant Health and continues to prioritize organic growth, despite challenges from discontinued offerings impacting revenue growth.
National Research Corporation (NASDAQ:NRC) will host a web simulcast of its Q2 2022 earnings conference call on August 3, 2022, following the market close on August 2, 2022, when the earnings results will be released. The live broadcast starts at 11:00 a.m. ET and will be available for replay for 30 days. NRC has over 40 years of experience in enhancing healthcare through Human Understanding, helping organizations improve customer experiences and trust.
Summary not available.
NRC Health announced a quarterly cash dividend of $0.24 per share payable on July 15, 2022, to shareholders on record by June 30, 2022. Additionally, the Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares. This buyback will occur based on market conditions and corporate considerations. The previous repurchase authorization has concluded, and the new one has no expiration date, reflecting NRC Health's commitment to enhancing shareholder value.
NRC Health has appointed Parul Bhandari, a Microsoft executive, to its Board of Directors as of May 19, 2022. Bhandari brings over 20 years of experience in technology and digital transformation, focusing on leveraging data and AI for healthcare improvement. Her role will enhance NRC's mission to foster Human Understanding in healthcare. With a solid background in business development and strategy, Bhandari aims to address the challenges of balancing technology with human-centric care delivery.
National Research Corporation (NASDAQ:NRC) reported an 8% revenue increase in Q1 2022, reaching $38.4 million compared to $35.5 million in Q1 2021. However, operating income fell by 3% to $11.7 million, and net income decreased to $8.5 million from $9.2 million year-over-year. Diluted earnings per share dropped to $0.34, down from $0.36. The company is focused on organic growth, enhancing core offerings like the Human Understanding Program, while also investing in innovation and employee benefits. Cash flow from operations decreased to $8.3 million, but net cash rose to $21.8 million.